On behalf of BioHealth Innovation Inc., Alexandria Venture Investments, LLC, Johnson & Johnson Innovation – JLABS @ Washington, DC, TEDCO, and Virginia Bio, we invite you to APPLY to be invited to the 4th Annual BioHealth Capital Region Virtual Investment Conference on September 28th & 29th.
Our Annual BioHealth Capital Region Investment Conference is being held to connect those entrepreneurs and companies seeking capital to all forms of investors that have capital. The BHCR is making steady progress in its ability to attract Venture Capital as over $1.2 Billion dollars has been invested here in the last 18 months in over 100 deals. These investments run the gamut from pre-seed to Series B and C’s and as large as a $250m which Viela BIO received in their Series A in 2018, Thrive with their $110m Series A, Arcellx and their $85m Series B and numerous other companies which we will highlight in this program. The region has also had some participants that have had their initial IPO’s including NextCure for $75 million and Viela Bio for $157 million to name a few. Congrats to all in the BHCR that have had positive financing events and the many more expected to close on new investments soon.
We hope you all have a positive experience at this 4th Annual BioHealth Capital Region Conference as we remain steadfast in our goal to become a Top 3 Bio Pharma Cluster by 2023, or sooner, and increase our current #4 Top BioPharma Cluster ranking by Genetic Engineering News (GEN).
Please Note – Application does not guarantee meetings with Investors. Apply today at https://bit.ly/BHCRInvestment2021.